All Programs

Use the tool below to view all available Series

Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
CME/CE
Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
0.25 credits
- Jennifer R. Brown, MD, PhD
0.25 credits
Double-Class Refractory CLL in Community Practice: Current and Future Management
Double-Class Refractory CLL in Community Practice: Current and Future Management
CME/CE
Double-Class Refractory CLL in Community Practice: Current and Future Management
0.25 credits
- John C. Byrd, MD
0.25 credits
Personalizing First-Line Therapy for CLL
Personalizing First-Line Therapy for CLL
CME/CE
Personalizing First-Line Therapy for CLL
0.25 credits
- William Wierda, MD, PhD
- Matthew S. Davids, MD, MMSc
0.25 credits
CME/CE In-Person Event
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
May 27, 2026
May 27, 2026
Miami Beach, Florida
1.00 credit Learn more
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
CME/CE In-Person Event
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
May 27, 2026
Miami Beach, Florida
1.00 credit Learn more
Severity Assessment: Can You Pin the Stage on the Patient?
Severity Assessment: Can You Pin the Stage on the Patient?
MinuteCE®
Severity Assessment: Can You Pin the Stage on the Patient?
1.00 program credit
- Jennifer Geremia, PA-C
- Brooke Hodnick, PA-C, MPAS
1.00 program credit
Case Review: Can You Crack This IBD Case? 
Case Review: Can You Crack This IBD Case? 
MinuteCE®
Case Review: Can You Crack This IBD Case? 
1.00 program credit
- David Rubin, MD
- Kimberly D. Orleck, PA-C
1.00 program credit
IBD Immunopathogenesis: Do You Know What You're Blocking?
IBD Immunopathogenesis: Do You Know What You're Blocking?
MinuteCE®
IBD Immunopathogenesis: Do You Know What You're Blocking?
1.00 program credit
- Kimberly D. Orleck, PA-C
- Brooke Hodnick, PA-C, MPAS
1.00 program credit
Treat-to-Target: Are We There Yet? 
Treat-to-Target: Are We There Yet? 
MinuteCE®
Treat-to-Target: Are We There Yet? 
1.00 program credit
- Kimberly D. Orleck, PA-C
- Jennifer Geremia, PA-C
1.00 program credit
The Slippery Slope of Overt Hepatic Encephalopathy
The Slippery Slope of Overt Hepatic Encephalopathy
MinuteCE®
The Slippery Slope of Overt Hepatic Encephalopathy
1.00 program credit
- Arun B. Jesudian, MD
- Nancy S. Reau, MD
1.00 program credit
Optimizing Care of the Hospitalized Patient With Overt Hepatic Encephalopathy
Optimizing Care of the Hospitalized Patient With Overt Hepatic Encephalopathy
MinuteCE®
Optimizing Care of the Hospitalized Patient With Overt Hepatic Encephalopathy
1.00 program credit
- Nancy S. Reau, MD
1.00 program credit
Current Treatment of Hepatic Encephalopathy: Is It Meeting Our Patients' Needs?
Current Treatment of Hepatic Encephalopathy: Is It Meeting Our Patients' Needs?
MinuteCE®
Current Treatment of Hepatic Encephalopathy: Is It Meeting Our Patients' Needs?
1.00 program credit
- Arun B. Jesudian, MD
1.00 program credit
Treatment of Hepatic Encephalopathy: Primary vs Secondary Prophylaxis
Treatment of Hepatic Encephalopathy: Primary vs Secondary Prophylaxis
MinuteCE®
Treatment of Hepatic Encephalopathy: Primary vs Secondary Prophylaxis
1.00 program credit
- Arun B. Jesudian, MD
- Nancy S. Reau, MD
1.00 program credit
Muscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
Muscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
CME/CE
Muscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
0.25 credits
- Jose Rubio, MD
0.25 credits
Updates in Major Depressive Disorder with Insomnia
Updates in Major Depressive Disorder with Insomnia
CME/CE
Updates in Major Depressive Disorder with Insomnia
0.50 credits
- Michael E. Thase, MD
- Andrew Krystal, MD
0.50 credits
Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer
Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer
MinuteCE®
Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer
0.50 program credits
- James M. Cleary, MD, PhD
0.50 program credits

All Programs

Popular

Title

Share on ReachMD